


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app17.us.archive.org';v.server_ms=797;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>External beam radiotherapy (EBRT) for bone metastases: percentage of patients, regardless of age, with a diagnosis of bone metastases and no history of previous radiation who receive EBRT with an acceptable fractionation scheme as defined by the guideline. | National Quality Measures Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/apple-touch-icon-NQMC.png">
    <link rel="icon" type="image/png" href="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/UI/images/manifest-NQMC.json">
    <link rel="mask-icon" href="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/safari-pinned-tab-NQMC.svg" color="#222c66">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180620173903cs_/https://www.qualitymeasures.ahrq.gov/cassette.axd/stylesheet/50802fec44b49e78c77b55e1df8361e3dbe9a339/NQMCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180620173903js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180620173903if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180620173903/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180620173903if_/https://www.googletagmanager.com/ns.html?id=GTM-KXQCDQ" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180620173903/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KXQCDQ');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180620173903/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180620173903/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/" class="header-logo NQMC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png">
				        <source srcset="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header_m.png">
				        <img src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png" alt="National Quality Measures Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NQMC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		        <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
		        <li>
                    <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/browse" class="parent-link">Measure Summaries</a>		            <ul class="level-2 dropdown">
		                    <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/domain">By Measure Domain</a></li>
                            <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/setting">By Measurement Setting</a></li>
		                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_DocType=302&amp;fLockTerm=Measure Summaries">All Summaries</a></li>
		            </ul>
		        </li>
		        <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
		        <li class="">
                    <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a>		        </li>
                <li class=""><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Quality Measures Clearinghouse (NQMC, qualitymeasures.ahrq.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NQMC as of that date. For additional information, read our <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Measure Summary</li>
            <li>NQMC:011031</li>
            <li>Feb 2017
            </li>            
                                </ul>
        <div>
                <h1>External beam radiotherapy (EBRT) for bone metastases: percentage of patients, regardless of age, with a diagnosis of bone metastases and no history of previous radiation who receive EBRT with an acceptable fractionation scheme as defined by the guideline.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Developer_String=American%20Society%20for%20Radiation%20Oncology&amp;fLockTerm=American%2BSociety%2Bfor%2BRadiation%2BOncology">American Society for Radiation Oncology</a></li>
                        <li>   
                                <a id="2484" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2017 Feb. &nbsp;19 p. </td></tr></table>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2012 Aug 9. 18 p. </p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
            <h4>Measure Hierarchy</h4>
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Collection_Hierarchy=objid47284&amp;fLockTerm=External%2BBeam%2BRadiotherapy%2Bfor%2BBone%2BMetastases">External Beam Radiotherapy for Bone Metastases</a>                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Infant%3A%20Newborn&amp;fLockTerm=Infant%253a%2BNewborn">Infant: Newborn</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Infant%3A%2001-23%20months%20old&amp;fLockTerm=Infant%253a%2B01-23%2Bmonths%2Bold">Infant: 01-23 months old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Child%3A%20Pre-school%3A%202-5%20years%20old&amp;fLockTerm=Child%253a%2BPre-school%253a%2B2-5%2Byears%2Bold">Child: Pre-school: 2-5 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Child%3A%206-12%20years%20old&amp;fLockTerm=Child%253a%2B6-12%2Byears%2Bold">Child: 6-12 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adolescent%3A%2013-18%20years%20old&amp;fLockTerm=Adolescent%253a%2B13-18%2Byears%2Bold">Adolescent: 13-18 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2019-44%20years%20old&amp;fLockTerm=Adult%253a%2B19-44%2Byears%2Bold">Adult: 19-44 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2045-64%20years%20old&amp;fLockTerm=Adult%253a%2B45-64%2Byears%2Bold">Adult: 45-64 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2065-79%20years%20old&amp;fLockTerm=Adult%253a%2B65-79%2Byears%2Bold">Adult: 65-79 years old</a></li>                                              
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2080%20years%20old%20and%20older&amp;fLockTerm=Adult%253a%2B80%2Byears%2Bold%2Band%2Bolder">Adult: 80 years old and older</a></li>                                              
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_ICD9CM_CUI=C0153690&amp;fLockTerm=Secondary+malignant+neoplasm+of+bone+and+bone+marrow">Secondary malignant neoplasm of bone and bone marrow</a>
 (198.5)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0002423&amp;fLockTerm=Ambulatory+Care">Ambulatory Care</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0002424&amp;fLockTerm=Ambulatory+Care+Facilities">Ambulatory Care Facilities</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0005967&amp;fLockTerm=Bone+Neoplasms">Bone Neoplasms</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0524811&amp;fLockTerm=Dose+Fractionation">Dose Fractionation</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C1522449&amp;fLockTerm=Radiotherapy">Radiotherapy</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0002424&amp;fLockTerm=Ambulatory+Care+Facilities">Ambulatory Care Facilities</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0002423&amp;fLockTerm=ambulatory+care+services">ambulatory care services</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0005967&amp;fLockTerm=Bone+neoplasms">Bone neoplasms</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0524811&amp;fLockTerm=Dose+Fractionation">Dose Fractionation</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C1517033&amp;fLockTerm=External+Beam+Radiation+Therapy">External Beam Radiation Therapy</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0279530&amp;fLockTerm=Malignant+Bone+Neoplasm">Malignant Bone Neoplasm</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C3161031&amp;fLockTerm=Radiotherapy+fractionation">Radiotherapy fractionation</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C1522449&amp;fLockTerm=Therapeutic+radiology+procedure">Therapeutic radiology procedure</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0279530&amp;fLockTerm=bone+cancer">bone cancer</a>
, <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C1522449&amp;fLockTerm=radiation+therapy">radiation therapy</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0002424&amp;fLockTerm=Ambulatory+care+site">Ambulatory care site</a>
 (35971002), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0475095&amp;fLockTerm=Bone+tumor%2fmetastasis+irradiation">Bone tumor/metastasis irradiation</a>
 (169345006), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0279530&amp;fLockTerm=Malignant+neoplasm+of+bone">Malignant neoplasm of bone</a>
 (428281000), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0563495&amp;fLockTerm=Metastasis+to+bone+of+unknown+primary">Metastasis to bone of unknown primary</a>
 (285618001), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0005967&amp;fLockTerm=Neoplasm+of+bone">Neoplasm of bone</a>
 (115239009), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0005967&amp;fLockTerm=Neoplasm+of+bone">Neoplasm of bone</a>
 (126537000), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0002423&amp;fLockTerm=Outpatient+service">Outpatient service</a>
 (7271000175108), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C1522449&amp;fLockTerm=Radiation+oncology+AND%2fOR+radiotherapy">Radiation oncology AND/OR radiotherapy</a>
 (108290001), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C1522449&amp;fLockTerm=Radiation+oncology+AND%2fOR+radiotherapy">Radiation oncology AND/OR radiotherapy</a>
 (53438000), <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0153690&amp;fLockTerm=Secondary+malignant+neoplasm+of+bone">Secondary malignant neoplasm of bone</a>
 (94222008)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#563" class="section-mark">Measure Domain</a></li>
                                    <li><a href="#566" class="section-mark">Brief Abstract</a></li>
                                    <li><a href="#573" class="section-mark">Evidence Supporting the Measure</a></li>
                                    <li><a href="#580" class="section-mark">State of Use of the Measure</a></li>
                                    <li><a href="#583" class="section-mark">Application of the Measure in its Current Use</a></li>
                                    <li><a href="#660" class="section-mark">National Strategy for Quality Improvement in Health Care</a></li>
                                    <li><a href="#590" class="section-mark">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></li>
                                    <li><a href="#593" class="section-mark">Data Collection for the Measure</a></li>
                                    <li><a href="#605" class="section-mark">Computation of the Measure</a></li>
                                    <li><a href="#615" class="section-mark">Identifying Information</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11031?contentType=pdf" class="pdf">.PDF 95.1 kb</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11031?contentType=word" class="word">Word Document 283.6 kb</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-11031?contentType=xml" class="xml">.XML 32.6 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180620173903/https://www.facebook.com/sharer/sharer.php?u=https://www.qualitymeasures.ahrq.gov/summaries/summary/50701/external-beam-radiotherapy-ebrt-for-bone-metastases-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-bone-metastases-and-no-history-of-previous-radiation-who-receive-ebrt-with-an-acceptable-fractionation-scheme-as-defined-by-the-guideline" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180620173903/https://twitter.com/share?text=&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/50701/external-beam-radiotherapy-ebrt-for-bone-metastases-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-bone-metastases-and-no-history-of-previous-radiation-who-receive-ebrt-with-an-acceptable-fractionation-scheme-as-defined-by-the-guideline" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180620173903/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/50701/external-beam-radiotherapy-ebrt-for-bone-metastases-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-bone-metastases-and-no-history-of-previous-radiation-who-receive-ebrt-with-an-acceptable-fractionation-scheme-as-defined-by-the-guideline&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180620173903/mailto:/?Subject=AHRQ: External beam radiotherapy (EBRT) for bone metastases: percentage of patients, regardless of age, with a diagnosis of bone metastases and no history of previous radiation who receive EBRT with an acceptable fractionation scheme as defined by the guideline.&amp;body=https://www.qualitymeasures.ahrq.gov/summaries/summary/50701/external-beam-radiotherapy-ebrt-for-bone-metastases-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-bone-metastases-and-no-history-of-previous-radiation-who-receive-ebrt-with-an-acceptable-fractionation-scheme-as-defined-by-the-guideline" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Quality Measures Clearinghouse (NQMC). Measure summary: External beam radiotherapy (EBRT) for bone metastases: percentage of patients, regardless of age, with a diagnosis of bone metastases and no history of previous radiation who receive EBRT with an acceptable fractionation scheme as defined by the guideline. In: National Quality Measures Clearinghouse (NQMC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2017 Feb 01. [cited 2018 Jun 20]. Available: https://www.qualitymeasures.ahrq.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=enw">EndNote</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=txt">Medlars</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=ris">ProCite</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701">RefWorks</a></li>
                            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/50701?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="50701" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="563" class="accordion-title section-563 is-active" role="tab" aria-expanded="true"><a href="#">Measure Domain</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Primary Measure Domain</a></h3>
                    <p>Clinical Quality Measures: Process</p>
                        <h3><a href="#">Secondary Measure Domain</a></h3>
                    <p>Does not apply to this measure</p>

            </div>
                <h2 id="566" class="accordion-title section-566 is-active" role="tab" aria-expanded="true"><a href="#">Brief Abstract</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description</a></h3>
                    <p><div class="content_para"><p>This measure is used to assess the percentage of patients, regardless of age, with a diagnosis of bone metastases and no history of previous radiation who receive external beam radiation therapy (EBRT) with an acceptable fractionation scheme as defined by the guideline once per reporting period, administered by a physician in an ambulatory care setting.</p></div></p>
                        <h3><a href="#">Rationale</a></h3>
                    <p><div class="content_para"><p>It is estimated that more than 1.6 million new cancer cases are expected to be diagnosed in 2016. Bone metastases, a common manifestation of malignancy, can significantly affect the quality of life for patients by causing debilitating effects including pain, spinal cord compression, hypercalcemia and pathologic fracture. Evidence shows that radiotherapy provides successful palliation of painful bone metastases. External beam radiation therapy (EBRT) can provide significant palliation to painful bone metastases in 50% to 80% of patients. Although the role of radiation therapy in palliation of bone metastases has been well established, literature shows widespread variation in the practice patterns for using radiation therapy for palliation. Even though several meta-analyses have shown the efficiency of using lower fractionation schedules, there has been a reluctance to adopt them. A most-recent survey studied international practice variations and found doses commonly prescribed ranging from 3Gy/1 fraction to 60Gy/20 fractions. Single fraction treatment was recommended in only 2% to 20% of cases presented in United States.</p>
<p>Numerous prospective randomized and retrospective trials have shown similar pain relief outcomes with shorter EBRT schedules than with longer courses of palliative radiation therapy (RT). The clinical practice guideline on "Palliative Radiotherapy for Bone Metastases" reviewed evidence from nine studies. The guideline states: "Although various fractionation schemes can provide good rates of palliation, numerous prospective randomized trials have shown that 30Gy in 10 fractions, 24Gy in 6 fractions, 20Gy in 5 fractions, or 8Gy in a single fraction can provide excellent pain control and minimal side effects. The longer course has the advantage of lower incidence of repeat treatment to the same site, and the single fraction has proved more convenient for patients and care givers."</p>
<p>Studies assessing patient preferences demonstrated that patients preferred short course treatments for reasons of convenience and fewer intrinsic costs associated with clinical visits. </p>
<p>This measure will monitor the appropriate use of EBRT for qualified patients and impact the quality of care provided to end of life patients needing palliation. This is a process measure intended to close the gap in treatment variation and ensures the use of an appropriate fractionation schedule, as well as prevents the overuse of radiation therapy. Also, the measure takes into account the effective schedule for relieving pain from bone metastases, patient preferences, time, and cost effectiveness.</p></div></p>
                        <h3><a href="#">Evidence for Rationale</a></h3>
                    <p><table><tr><td>American Cancer Society (ACS). Cancer facts &amp; figures 2011. Atlanta (GA): American Cancer Society (ACS); 2011. 60 p. </td></tr></table></p>
                    <p><table><tr><td>American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2017 Feb. &nbsp;19 p. </td></tr></table></p>
                    <p><table><tr><td>Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol. 1999 Aug;52(2):111-21. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10577696" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012 Mar;24(2):112-24. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22130630" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001 Jun;27(3):165-76. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11417967" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Dy SM, Lorenz KA, O'Neill SM, Asch SM, Walling AM, Tisnado D, Antonio AL, Malin JL. Cancer Quality-ASSIST supportive oncology quality indicator set: feasibility, reliability, and validity testing. Cancer. 2010 Jul 1;116(13):3267-75. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20564637" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, de Dios NR, Castillejo AR, Bassols ML, Galán JL, Conejo IM, López MA. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008 Nov;89(2):150-5. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18556080" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005 Jun 1;97(11):798-804. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15928300" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):161-7. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9747834" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, Lagerlund M, Bruland O. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol. 2006 Jun;79(3):278-84.</td></tr></table></p>
                    <p><table><tr><td>Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, Wong R, Hahn C. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017 Jan-Feb;7(1):4-12. [39 references] <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=27663933" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, Bruner DW, Hartsell W, American Society for Radiation Oncology (ASTRO). Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):965-76. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21277118" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998 Jun;47(3):233-40. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9681885" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Roos DE, Turner SL, OBrien PC, Smith JG, Spry NA, Burmeister BH, Hoskin PJ, Ball DL, Trans-Tasman Radiation Oncology Group, TROG 96.05. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol. 2005 Apr;75(1):54-63. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15878101" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S. Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. Radiother Oncol. 2009 May;91(2):261-6. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19307034" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E, Leer J, van Mierlo T. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999 Aug;52(2):101-9. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10577695" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>van der Linden Y, Roos D, Lutz S, Fairchild A. International variations in radiotherapy fractionation for bone metastases: geographic borders define practice patterns?. Clin Oncol (R Coll Radiol). 2009 Nov;21(9):655-8. <a href="https://web.archive.org/web/20180620173903/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19733039" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Primary Health Components</a></h3>
                    <p><div class="content_para"><p>Cancer; bone metastases; external beam radiation therapy (EBRT); fractionation schemes</p></div></p>
                        <h3><a href="#">Denominator Description</a></h3>
                    <p><div class="content_para"><p>All patients with bone metastases and no previous radiation to the same anatomic site who receive external beam radiation therapy (EBRT) for the treatment of bone metastases (see the related "Denominator Inclusions/Exclusions" field)</p></div></p>
                        <h3><a href="#">Numerator Description</a></h3>
                    <p><div class="content_para"><p>All patients, regardless of age, with bone metastases and no previous radiation to the same anatomic site who receive external beam radiation therapy (EBRT) for the treatment of bone metastases with any of the following recommended fractionation schemes: 30Gy/10fxns, 24Gy/6fxns, 20Gy/5fxns, 8Gy/1fxn (see the related "Numerator Inclusions/Exclusions" field)</p></div></p>

            </div>
                <h2 id="573" class="accordion-title section-573 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Criterion of Quality for the Measure</a></h3>
                    <p><ul><li>A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence</li><li>A systematic review of the clinical research literature (e.g., Cochrane Review)</li><li>One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal</li></ul></p>
                        <h3><a href="#">Additional Information Supporting Need for the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Extent of Measure Testing</a></h3>
                    <p><div class="content_para"><p>The face validity of the measure was tested using an online survey data collection instrument. The sample size included 20 radiation oncologists primarily involved in quality improvement and guideline development. Additionally, this project was statistically powered to identify significant differences between levels of the measure's reliability using the kappa statistic. Inter-rater reliability was tested for the critical data elements. Each abstraction tool which created a side-by-side comparison of the two medical records. The abstractors adjudicated any mismatches and after a consensus process that the appropriate answer was selected. A reason code for the mismatch was assigned for that data element.</p></div></p>
                        <h3><a href="#">Evidence for Extent of Measure Testing</a></h3>
                    <p><table><tr><td>American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2017 Feb. &nbsp;19 p. </td></tr></table></p>
                        <h3><a href="#">National Guideline Clearinghouse Link</a></h3>
                    <p><a href="https://web.archive.org/web/20180620173903/http://www.guideline.gov/content.aspx?id=50624" target="_blank">Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline.</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></p>

            </div>
                <h2 id="580" class="accordion-title section-580 is-active" role="tab" aria-expanded="true"><a href="#">State of Use of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">State of Use</a></h3>
                    <p>Current routine use</p>
                        <h3><a href="#">Current Use</a></h3>
                    <p>Internal quality improvement</p>
                    <p>Pay-for-reporting</p>
                    <p>Public reporting</p>

            </div>
                <h2 id="583" class="accordion-title section-583 is-active" role="tab" aria-expanded="true"><a href="#">Application of the Measure in its Current Use</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measurement Setting</a></h3>
                    <p>Ambulatory/Office-based Care</p>
                    <p>Hospital Outpatient</p>
                        <h3><a href="#">Professionals Involved in Delivery of Health Services</a></h3>
                    <p>Physicians</p>
                        <h3><a href="#">Least Aggregated Level of Services Delivery Addressed</a></h3>
                    <p>Individual Clinicians or Public Health Professionals</p>
                        <h3><a href="#">Statement of Acceptable Minimum Sample Size</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Target Population Age</a></h3>
                    <p><div class="content_para"><p>All ages</p></div></p>
                        <h3><a href="#">Target Population Gender</a></h3>
                    <p>Either male or female</p>

            </div>
                <h2 id="660" class="accordion-title section-660 is-active" role="tab" aria-expanded="true"><a href="#">National Strategy for Quality Improvement in Health Care</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">National Quality Strategy Aim</a></h3>
                    <p>Better Care</p>
                        <h3><a href="#">National Quality Strategy Priority</a></h3>
                    <p>Making Quality Care More Affordable<br/>Prevention and Treatment of Leading Causes of Mortality</p>

            </div>
                <h2 id="590" class="accordion-title section-590 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>End of Life Care</p>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Efficiency</p>

            </div>
                <h2 id="593" class="accordion-title section-593 is-active" role="tab" aria-expanded="true"><a href="#">Data Collection for the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Case Finding Period</a></h3>
                    <p><div class="content_para"><p>The reporting period</p></div></p>
                        <h3><a href="#">Denominator Sampling Frame</a></h3>
                    <p>Patients associated with provider</p>
                        <h3><a href="#">Denominator (Index) Event or Characteristic</a></h3>
                    <p>Clinical Condition</p>
                    <p>Therapeutic Intervention</p>
                        <h3><a href="#">Denominator Time Window</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Denominator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
All patients with bone metastases and no previous radiation to the same anatomic site who receive external beam radiation therapy (EBRT) for the treatment of bone metastases</p>
<p><strong>Exclusions</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>The EBRT is used to treat anything other than bone metastases; </li>
    <li>Previous radiation treatment to the same anatomic site (i.e., retreatment); </li>
    <li>Patients who are part of a prospective clinical protocol or registry study involving the administration of radiation therapy, especially stereotactic radiosurgery (SRS) or stereotactic body radiation therapy (SBRT); </li>
    <li>Patients with femoral axis cortical involvement greater than 3 cm in length if the current EBRT is to that femur; </li>
    <li>Patients who have undergone a surgical stabilization procedure if at the site of the current EBRT treatment; and </li>
    <li>Patients with spinal cord compression, cauda equina compression or radicular pain documented in the chart as related to the bone metastases being treated. </li>
    <li>Patient declines treatment </li>
</ol></div></p>
                        <h3><a href="#">Exclusions/Exceptions</a></h3>
                    <p>Medical factors addressed</p>
                    <p>Patient factors addressed</p>
                    <p>System factors addressed</p>
                        <h3><a href="#">Numerator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
All patients, regardless of age, with bone metastases and no previous radiation to the same anatomic site who receive external beam radiation therapy (EBRT) for the treatment of bone metastases with any of the following recommended fractionation schemes: 30Gy/10fxns, 24Gy/6fxns, 20Gy/5fxns, 8Gy/1fxn</p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for specific Current Procedural Terminology (CPT) codes for therapeutic radiology treatment planning in the ambulatory setting and therapeutic radiology treatment delivery in the hospital setting. </p>
<p><strong>Exclusions</strong><br/>
Unspecified</p></div></p>
                        <h3><a href="#">Numerator Search Strategy</a></h3>
                    <p>Fixed time period or point in time</p>
                        <h3><a href="#">Data Source</a></h3>
                    <p>Administrative clinical data</p>
                    <p>Electronic health/medical record</p>
                    <p>Imaging data</p>
                    <p>Paper medical record</p>
                    <p>Registry data</p>
                        <h3><a href="#">Type of Health State</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Instruments Used and/or Associated with the Measure</a></h3>
                    <p><div class="content_para"><p>2017 Measure Flow - OP-33: External Beam Radiotherapy for Bone Metastases.</p></div></p>

            </div>
                <h2 id="605" class="accordion-title section-605 is-active" role="tab" aria-expanded="true"><a href="#">Computation of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measure Specifies Disaggregation</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Scoring</a></h3>
                    <p>Rate/Proportion</p>
                        <h3><a href="#">Interpretation of Score</a></h3>
                    <p>Desired value is a higher score</p>
                        <h3><a href="#">Allowance for Patient or Population Factors</a></h3>
                    <p>Unspecified</p>
                        <h3><a href="#">Standard of Comparison</a></h3>
                    <p>External comparison at a point in, or interval of, time</p>
                    <p>Internal time comparison</p>

            </div>
                <h2 id="615" class="accordion-title section-615 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Original Title</a></h3>
                    <p><div class="content_para"><p>External beam radiotherapy for bone metastases.</p></div></p>
                        <h3><a href="#">Measure Collection Name</a></h3>
                    <p>External Beam Radiotherapy for Bone Metastases</p>
                        <h3><a href="#">Submitter</a></h3>
                    <p>American Society for Radiation Oncology - Medical Specialty Society</p>
                        <h3><a href="#">Developer</a></h3>
                    <p>American Society for Radiation Oncology - Medical Specialty Society</p>
                        <h3><a href="#">Funding Source(s)</a></h3>
                    <p><div class="content_para"><p>American Society for Radiation Oncology (ASTRO)</p></div></p>
                        <h3><a href="#">Composition of the Group that Developed the Measure</a></h3>
                    <p><div class="content_para"><p>Anushree Vichare, MBBS MPH, Measures Development Manager, American Society for Radiation Oncology (ASTRO); Emily Wilson, Vice-President, Advocacy &amp; Clinical Affairs Division, ASTRO</p></div></p>
                        <h3><a href="#">Financial Disclosures/Other Potential Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>None</p></div></p>
                        <h3><a href="#">Measure Initiative(s)</a></h3>
                    <p>Hospital Compare</p>
                    <p>Hospital Outpatient Quality Reporting Program</p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>This measure was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date of Most Current Version in NQMC</a></h3>
                    <p>2017 Feb</p>
                        <h3><a href="#">Measure Maintenance</a></h3>
                    <p><div class="content_para"><p>Three years</p></div></p>
                        <h3><a href="#">Date of Next Anticipated Revision</a></h3>
                    <p><div class="content_para"><p>Three years from date of submission</p></div></p>
                        <h3><a href="#">Measure Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2012 Aug 9. 18 p. </p></div></p>
                        <h3><a href="#">Source(s)</a></h3>
                    <p><table><tr><td>American Society for Radiation Oncology (ASTRO). National Quality Measures Clearinghouse (NQMC) measure submission form: external beam radiotherapy for bone metastases. 2017 Feb. &nbsp;19 p. </td></tr></table></p>
                        <h3><a href="#">Measure Availability</a></h3>
                    <p><div class="content_para"><p>Source not available electronically.</p>
<p>For more information, contact the American Society for Radiation Oncology (ASTRO) at 8280 Willow Oaks Corporate Drive, Suite 500, Fairfax, VA 22031; Phone: 703-502-1550; Fax: 703-502-7852; Web site: <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=50701&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.astro.org" title="ASTRO Web site">www.astro.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>. </p></div></p>
                        <h3><a href="#">NQMC Status</a></h3>
                    <p><div class="content_para"><p>This NQMC summary was completed by ECRI Institute on February 26, 2014. The information was verified by the measure developer on March 25, 2014.</p>
<p>This NQMC summary was updated by ECRI Institute on March 28, 2017. The information was verified by the measure developer on April 5, 2017.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.</p>
<p>For more information, contact the American Society for Radiation Oncology (ASTRO) at 8280 Willow Oaks Corporate Drive, Suite 500, Fairfax, VA 22031; Phone: 703-502-1550; Fax: 703-502-7852; Web site: <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=50701&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.astro.org" title="ASTRO Web site">www.astro.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>. </p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NQMC Disclaimer</a></h3>
                    <p><p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NQMC Measure Summaries</h3>
            <p>NQMC provides structured summaries containing information about measures and their development.</p>
            <ul>
                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/domain-framework" class="internal-link">Domain Framework</a></li>
                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/template-of-measure-attributes" class="internal-link">Template of Measure Attributes</a></li>
                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/faqs" class="help-button">Measure Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->
        <div class="hhs-block">
            <h3 class="hhs-header">Related HHS Measure</h3>
            <p>From the HHS Measure Inventory</p>
                <p><a target="_blank" class="external-link" href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/hhs/content.aspx?id=3837">External beam radiotherapy for bone metastases: This measure reports the percentage of patients, regardless of age, with a diagnosis of painful bone metastases and no history of previous radiation who receive external beam radiation therapy (EBRT) with an acceptable fractionation scheme as defined by the guideline.</a></p>   
                <p><a target="_blank" class="external-link" href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/hhs/content.aspx?id=3864">External beam radiotherapy for bone metastases: This measure reports the percentage of patients, regardless of age, with a diagnosis of painful bone metastases and no history of previous radiation who receive external beam radiation therapy&nbsp;(EBRT) with an acceptable fractionation scheme as defined by the guideline.</a></p>   
        </div>
        <!-- /.HSS Block -->    

    <!-- Related Content -->
        <h3>Related Content</h3>
        <h4 class="prefix-icon guideline">NGC GUIDELINE SUMMARIES</h4>
        <div class="content-list-wrap">
                <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011142</li>
            <li>2017 Jan-Feb</li>
        </ul>
       
             <p><a class="external-link" target="_blank" href="https://web.archive.org/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/summary/50624/Palliative-radiation-therapy-for-bone-metastases-update-of-an-ASTRO-evidencebased-guideline">Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline.</a></p>
    </div>

        </div>


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NQMC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/rssFiles/nqmc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon measure news-list-category-label">Measure Summaries</h5>
    
    <a class="block-link" href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/disclaimer?id=50701&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.svg">
					  	<img src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.png" alt="NQMC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/organization" class="parent-link">Measure Summaries</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/rss">RSS</a></li>
					    <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/browse/related">Related NGC Guidelines</a></li>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180620173903/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
					<li><!-- NGC footer link -->
						<a href="https://web.archive.org/web/20180620173903/https://www.guideline.gov/" target="_blank" class="partner-button ngc">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.svg">
									<img src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.png" alt="National Guidelines Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/NGC footer link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180620173903/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180620173903im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180620173903/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180620173903/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180620173903js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180620173903js_/https://www.qualitymeasures.ahrq.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 17:39:03 Jun 20, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:51:21 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 560.586 (3)
  esindex: 0.006
  captures_list: 598.805
  CDXLines.iter: 17.341 (3)
  PetaboxLoader3.datanode: 83.526 (4)
  exclusion.robots: 0.298
  exclusion.robots.policy: 0.28
  RedisCDXSource: 17.189
  PetaboxLoader3.resolve: 508.653 (3)
  load_resource: 130.318
-->